Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2026

Stockholders’ Equity [Abstract]

Schedule of Company Issued Shares of Restricted Common Stock

Effective January 28, 2026, the Company issued shares of restricted common stock, representing compensation for services to be rendered in 2026 and 2027, to the Company’s executive officers and Board members as follows:

Name	Position	No. of Shares of Restricted Common Stock
Bryan McLaren	Chairman of the Board, Chief Executive Officer and Chief Financial Officer		250,000
Berekk Blackwell	President and Chief Operating Officer		150,000
Art Friedman	Independent Director		200,000
David G. Honaman	Independent Director		200,000
Cole Stevens	Independent Director		200,000

Schedule of Stock Option Activities

Stock option activities for the three months ended March 31, 2026 are summarized as follows:

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Balance outstanding at December 31, 2025		1,565,000			0.79		5.65	$	8,400
Forfeited		(358,750	)		0.69				-
Balance outstanding at March 31, 2026		1,206,250		$	0.82		4.87	$	-
Exercisable, March 31, 2026		1,206,250		$	0.82		4.87	$	-
Balance non-vested on December 31, 2025		358,750		$	0.69		7.45	$	-
Forfeited		(358,750	)		0.69		-
Vested during the period		-			-		-		-
Balance non-vested on March 31, 2026		-		$	-		-	$	-